{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:03:13Z","timestamp":1775070193115,"version":"3.50.1"},"reference-count":66,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: With the rising incidence of obesity-related endometrial cancer, there is renewed interest in physiologic, low-cost approaches to identify women with hormonally active endometrium who may benefit from early preventive interventions. The progesterone challenge test (PCT), an established clinical tool for evaluating amenorrhea, has been previously proposed as a method to detect endometrial pathology. This study systematically evaluated the diagnostic accuracy of the PCT for detecting endometrial hyperplasia, intraepithelial neoplasia, and carcinoma in asymptomatic postmenopausal women to determine its potential role as a physiologic marker of endometrial cancer risk. Methods: A systematic review and meta-analysis were conducted following PRISMA-DTA guidelines. MEDLINE, EMBASE, EBM Reviews, and CINAHL were searched from inception to 20 January 2025, along with ClinicalTrials.gov and grey literature. Eligible studies prospectively evaluated the PCT with endometrial biopsy as the reference standard. Data extraction and risk-of-bias assessment were performed in duplicate. Risk of bias was assessed using QUADAS-2. Pooled sensitivity, specificity, and predictive values were estimated using hierarchical summary receiver operating characteristic models. Results: Nineteen studies (n = 3902) met the inclusion criteria. The pooled sensitivity and specificity of the PCT for detecting endometrial pathology were 95% (95% CI 86\u2013100%) and 87% (76\u201396%), respectively. The positive predictive value was 32% (95% CI, 16\u201350%) and the negative predictive value was 100% (100\u2013100%). When endometrial proliferation was included in the target condition, sensitivity decreased to 82%, but positive predictive value increased to 70%. Conclusions: The PCT shows high diagnostic accuracy for identifying estrogen-driven endometrial pathology in asymptomatic postmenopausal women. Re-evaluating this simple, physiologic test as a functional risk-stratification tool could inform precision prevention strategies for endometrial cancer.<\/jats:p>","DOI":"10.3390\/diagnostics16030378","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:52:38Z","timestamp":1769190758000},"page":"378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Re-Evaluating the Progesterone Challenge Test as a Physiologic Marker of Endometrial Cancer Risk: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"16","author":[{"given":"Rachel J.","family":"Woima","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-4881","authenticated-orcid":false,"given":"Derek S.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise Abi","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-282X","authenticated-orcid":false,"given":"Sabine","family":"El-Halabi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1176-2622","authenticated-orcid":false,"given":"Andrea","family":"Neilson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Bernard","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, McGill University Health Centre (MUHC), McGill University, Montr\u00e9al, QC H4A 0B1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6003-485X","authenticated-orcid":false,"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7760-410X","authenticated-orcid":false,"given":"Aline","family":"Talhouk","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"7","article-title":"Cancer Statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers","volume":"37","author":"Clarke","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajog.2011.05.042","article-title":"Understanding Obesity and Endometrial Cancer Risk: Opportunities for Prevention","volume":"205","author":"Schmandt","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2510961","DOI":"10.1080\/09540105.2025.2510961","article-title":"Obesity and Endometrial Cancer: Biological Mechanisms, Nutritional Strategies, and Clinical Perspectives","volume":"36","author":"Memoli","year":"2025","journal-title":"Food Agric. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2009.02.032","article-title":"Incidence of Endometrial Hyperplasia","volume":"200","author":"Reed","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","first-page":"1531","article-title":"Obesity, Endogenous Hormones, and Endometrial Cancer Risk","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial Cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/modpathol.3800328","article-title":"Prediction of Endometrial Carcinoma by Subjective Endometrial Intraepithelial Neoplasia Diagnosis","volume":"18","author":"Hecht","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"896.e1","DOI":"10.1016\/j.ajog.2020.06.045","article-title":"Long-Term Outcome of Postmenopausal Women with Proliferative Endometrium on Endometrial Sampling","volume":"223","author":"Rotenberg","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Nonsurgical Approach for Complex Atypical Hyperplasia and Early-Stage Endometrial Cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1200\/JCO.2016.70.5822","article-title":"Intentional Weight Loss and Endometrial Cancer Risk","volume":"35","author":"Luo","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.31913","article-title":"The Impact of Obesity and Bariatric Surgery on Circulating and Tissue Biomarkers of Endometrial Cancer Risk","volume":"144","author":"MacKintosh","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","article-title":"Levonorgestrel-Releasing Intrauterine System Use Is Associated with a Decreased Risk of Ovarian and Endometrial Cancer, without Increased Risk of Breast Cancer. Results from the NOWAC Study","volume":"149","author":"Jareid","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1471-0528.16108","article-title":"Metformin plus Megestrol Acetate Compared with Megestrol Acetate Alone as Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia and Well-differentiated Endometrial Cancer: A Randomised Controlled Trial","volume":"127","author":"Yang","year":"2020","journal-title":"BJOG"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3802\/jgo.2016.27.e8","article-title":"Therapeutic Options for Management of Endometrial Hyperplasia","volume":"27","author":"Chandra","year":"2016","journal-title":"J. Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/AOG.0b013e31817d53a4","article-title":"Cost-Effectiveness Analysis of Endometrial Cancer Prevention Strategies for Obese Women","volume":"112","author":"Kwon","year":"2008","journal-title":"Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/AOG.0000000000001616","article-title":"Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis","volume":"128","author":"Dottino","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the Care of Individuals with an Inherited Predisposition to Lynch Syndrome","volume":"296","author":"Lindor","year":"2006","journal-title":"JAMA"},{"key":"ref_20","first-page":"732","article-title":"Use of the Progestogen Challenge Test to Reduce the Risk of Endometrial Cancer","volume":"55","author":"Gambrell","year":"1980","journal-title":"Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1210\/jc.2017-00131","article-title":"Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline","volume":"102","author":"Gordon","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jmig.2013.08.707","article-title":"Impact of Obesity on Outcomes of Hysterectomy","volume":"21","author":"McMahon","year":"2014","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred Reporting Items for a Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"m2632","DOI":"10.1136\/bmj.m2632","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA): Explanation, Elaboration, and Checklist","volume":"370","author":"Salameh","year":"2020","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1002\/hsr2.178","article-title":"Arcsine-based Transformations for Meta-analysis of Proportions: Pros, Cons, and Alternatives","volume":"3","author":"Lin","year":"2020","journal-title":"Health Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"IntHout, J., Ioannidis, J.P., and Borm, G.F. (2014). The Hartung-Knapp-Sidik-Jonkman Method for Random Effects Meta-Analysis Is Straightforward and Considerably Outperforms the Standard DerSimonian-Laird Method. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-25"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1177\/0962280215592269","article-title":"Performance of Methods for Meta-Analysis of Diagnostic Test Accuracy with Few Studies or Sparse Data","volume":"26","author":"Takwoingi","year":"2017","journal-title":"Stat. Methods Med. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A Hierarchical Regression Approach to Meta-Analysis of Diagnostic Test Accuracy Evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Stat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate Analysis of Sensitivity and Specificity Produces Informative Summary Measures in Diagnostic Reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J. Clin. Epidemiol."},{"key":"ref_31","unstructured":"Schiller, I., and Dendukuri, N. (HSROC: Joint Meta-Analysis of Diagnostic Test Sensitivity and Specificity with or Without a Gold Standard Reference Test, 2019). HSROC: Joint Meta-Analysis of Diagnostic Test Sensitivity and Specificity with or Without a Gold Standard Reference Test, R Package Version 2.1.9."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to Perform a Meta-Analysis with R: A Practical Tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-5122(94)90041-8","article-title":"Progesterone Challenge Test in Postmenopausal Women at High Risk","volume":"19","author":"Wafa","year":"1994","journal-title":"Maturitas"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0020-7292(95)02554-5","article-title":"Transvaginal Sonography and Progesterone Challenge for Identifying Endometrial Pathology in Postmenopausal Women","volume":"52","author":"Malinova","year":"1996","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_35","first-page":"22","article-title":"Progesterone Challenge Test for Evaluation of Endometrial Hyperplasia in Postmenopausal Women","volume":"40","author":"Pehlivanov","year":"1998","journal-title":"Folia Med."},{"key":"ref_36","first-page":"135","article-title":"Transvaginal Sonography and Progesterone Challenge Test for Identifying Endometrial Pathology in Post Menopausal Women","volume":"52","author":"Rani","year":"2002","journal-title":"J. Obstet. Gynaecol. India"},{"key":"ref_37","first-page":"6","article-title":"Evaluating the Endometrium in Women on Tamoxifen: A Pilot Study to Compare a \u201cGold Standard\u201d with an \u201cOld Standard\u201d","volume":"4","author":"Guerrieri","year":"1997","journal-title":"Menopause"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/gme.0b013e3181ca2513","article-title":"Value of the Progesterone Test in Screening for Endometrial Pathology in Asymptomatic Postmenopausal Women Receiving Treatment with Tamoxifen","volume":"17","author":"Fernandez","year":"2010","journal-title":"Menopause"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0002-9378(83)90238-7","article-title":"Detection of Postmenopausal Women at Risk for Endometrial Carcinoma by a Progesterone Challenge Test","volume":"147","author":"Hanna","year":"1983","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0020-7292(88)90205-6","article-title":"Progesterone Challenge Test and Estrogen Assays in Menopausal Women with Endometrial Adenomatous Hyperplasia","volume":"26","author":"Toppozada","year":"1988","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0020-7292(93)90375-7","article-title":"Progesterone Challenge Test for the Assessment of Endometrial Pathology in Asymptomatic Menopausal Women","volume":"40","author":"Macia","year":"1993","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_42","first-page":"746","article-title":"Progesterone Challenge Test in Screening Asymptomatic Postmenopausal Women for Cancer Endometrium","volume":"45","author":"Deka","year":"1995","journal-title":"J. Obstet. Gynaecol. India"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1590\/S1516-31801996000300005","article-title":"The Progestogen Challenge Test in Postmenopausal Women: Clinical and Morphologic Aspects","volume":"114","author":"Bortoletto","year":"1996","journal-title":"Sao Paulo Med. J."},{"key":"ref_44","first-page":"91","article-title":"D\u00e9pistage Des Hyperplasies et Des Cancers de l\u2019endom\u00e8tre","volume":"79","author":"Erny","year":"1984","journal-title":"Rev. Fr. Gyn\u00e9col. Obst\u00e9t."},{"key":"ref_45","first-page":"371","article-title":"Le Test \u00e0 La Progest\u00e9rone Est-Il La M\u00e9thode G\u00e9n\u00e9ralisable de D\u00e9pistage Des L\u00e9sions N\u00e9oplasiques et Pr\u00e9n\u00e9oplasiques de l\u2019endom\u00e8tre?","volume":"77","author":"Viel","year":"1990","journal-title":"Bull. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000292769","article-title":"Combined Use of Progesterone Challenge Test and Endometrium Thickness Evaluated by Transvaginal Ultrasonography in the Preventive Management of Postmenopausal Women","volume":"34","author":"Pansini","year":"1992","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0301-2115(96)02493-1","article-title":"Sequential Addition of Low Dose of Medrogestone or Medroxyprogesterone Acetate to Transdermal Estradiol: A Pilot Study on Their Influence on the Endometrium","volume":"68","author":"Pansini","year":"1996","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_48","first-page":"195","article-title":"Progestogen Tests after the Menopause","volume":"81","author":"Erny","year":"1986","journal-title":"Rev. Fr. Gynecol. Obstet."},{"key":"ref_49","unstructured":"Madhuri, K. Progesterone Challenge Test in Screening Postmenopausal Women for Risk of Endometrial Carcinoma a Comparative Study with Endometrial Thickness by Transvaginal Sonography. [Doctoral Dissertation, N.T.R. University of Health Sciences]. Available online: https:\/\/www.proquest.com\/pqdtglobal\/docview\/2323168415\/9D6B6B6A486E48D0PQ\/1?accountid=14906&sourcetype=Dissertations%20&%20Theses."},{"key":"ref_50","first-page":"156","article-title":"Effect of Initial Gestagen Treatment on Bleeding Patterns in Postmenopausal Women Receiving Continuous Combined Hormone Replacement Therapy","volume":"6","year":"1999","journal-title":"Menopause"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0020-7292(93)90521-W","article-title":"Progestin Challenge Test in Postmenopausal Patients","volume":"43","author":"Valenzuela","year":"1993","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmjsrh-2020-200619","article-title":"Norethisterone and Its Acetate\u2014What\u2019s so Special about Them?","volume":"47","author":"Huvinen","year":"2021","journal-title":"BMJ Sex. Reprod. Health"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Houshdaran, S., Chen, J.C., Vallv\u00e9-Juanico, J., Balayan, S., Vo, K.C., Smith-McCune, K., Greenblatt, R.M., Irwin, J.C., and Giudice, L.C. (2020). Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072625"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"P235","DOI":"10.1016\/j.ultrasmedbio.2006.02.1043","article-title":"The Value of Progesterone Challenge Test Combined with Transvaginal Ultrasonography Detect Endometrial Disease in Postmenopausal Asymptomatic Women","volume":"32","author":"Chu","year":"2006","journal-title":"Ultrasound Med. Biol."},{"key":"ref_55","first-page":"287","article-title":"Progesterone Challenge Test and Transvaginal Ultrasonography in the Detection of Endometrial Pathology in Postmenopausal Women","volume":"19","author":"Wang","year":"2004","journal-title":"QiLu Med. J."},{"key":"ref_56","unstructured":"Petranick, K., Bewtra, C., and Gallagher, J.C. (1995, January 20\u201323). Use of Progestin Challenge Test in Elderly Women K.: P-73. Proceedings of the Abstracts: Sixth Annual Meeting of the North American Menopause Society: POSTER PRESENTATIONS, Chicago, IL, USA."},{"key":"ref_57","first-page":"24","article-title":"The Early Detection and Screening of Endometrial Carcinoma by the Progesterone Test and Uterine Sonography","volume":"32","author":"Ivanov","year":"1993","journal-title":"Akusherstvo Ginekol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2050312119848247","DOI":"10.1177\/2050312119848247","article-title":"Endometrial Polyps: Pathogenesis, Sequelae and Treatment","volume":"7","author":"Nijkang","year":"2019","journal-title":"SAGE Open Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1469-0705.1995.06060435.x","article-title":"Endometrial Evaluation in Postmenopausal Breast Cancer Patients Receiving Tamoxifen: An Ultrasound, Color Flow Doppler, Hysteroscopic and Histological Study","volume":"6","author":"Exacoustos","year":"1995","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1034\/j.1600-0412.2001.801210.x","article-title":"Dilatation and Curettage Fails to Detect Most Focal Lesions in the Uterine Cavity in Women with Postmenopausal Bleeding","volume":"80","author":"Epstein","year":"2001","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00404-022-06540-1","article-title":"The Significance of \u201cAtrophic Endometrium\u201d in Women with Postmenopausal Bleeding","volume":"306","author":"Rotenberg","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5122(03)00068-9","article-title":"Pathophysiology of Endometrial Bleeding","volume":"45","author":"Ferenczy","year":"2003","journal-title":"Maturitas"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2023.04.271","article-title":"Reappraising 21 Years of the WHI Study: Putting the Findings in Context for Clinical Practice","volume":"174","author":"Stute","year":"2023","journal-title":"Maturitas"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.maturitas.2003.10.006","article-title":"Clinical Usefulness of Endometrial Screening by Ultrasound in Asymptomatic Postmenopausal Women","volume":"48","author":"Gambacciani","year":"2004","journal-title":"Maturitas"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2147\/CMAR.S294074","article-title":"New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?","volume":"14","author":"Saccardi","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N. Engl. J. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/3\/378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:38Z","timestamp":1769191358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/3\/378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["diagnostics16030378"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16030378","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}